Growth in Interventional Urology was negatively impacted by a voluntary product recall in Bladder Health and Surgery (around DKK 25 million in Q1), partly offset by solid performance in Endourology.

Q1 2025. Management View. CEO Kristian Villumsen highlighted 8% organic growth and a reported EBIT margin of 27% for Q1 2025, w ...

December 2024 Coloplast delivered 8% organic growth and an EBIT margin1 of 27% in Q1, in line with expectations. Reported ...

Europe medical device market was valued at $144.4 billion in 2022 and will grow by 4.7% annually over 2022-2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of ...

North America medical device market is projected to grow by 3.9% annually in the forecast period and reach $ 282.3 billion by 2032, driven by the prevalence of infectious diseases as well as the ...

When diagnosed with cancer, it is not uncommon for individuals to ask themselves: "Why me?" But Mr Ellil Mathiyan Lakshmanan, when diagnosed with rectal cancer in 2011 and subsequently with testicular ...

Discover the latest research on the management of venous leg ulcers. This Consensus Statement provides concise guidance for healthcare providers in Canada.

The Syrian factions that toppled President Bashar Assad last month named an Islamist former rebel leader as the country‘s ...

The stoma/ostomy care market is projected to grow at a 4.9% CAGR, reaching USD 6.5 billion by 2033. The rising prevalence of ...

In a report released today, Graham Doyle from UBS maintained a Buy rating on ConvaTec (CTEC – Research Report), with a price target of p360.00.

Barclays analyst Hassan Al-Wakeel maintained a Buy rating on ConvaTec (CTEC – Research Report) today and set a price target of £3.20. The ...

The Supreme Court agreed Friday to take on a new culture war dispute: whether the nation’s first publicly funded religious charter school should be allowed to open in Oklahoma.